Point72 Middle East FZE’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-36,216
Closed -$326K 894
2023
Q4
$326K Buy
36,216
+11,211
+45% +$101K 0.01% 484
2023
Q3
$224K Buy
25,005
+11,587
+86% +$104K 0.01% 542
2023
Q2
$206K Buy
+13,418
New +$206K 0.01% 597